LGI1 antibodyrelated limbic encephalitis: a case report and literature review

doi:10.3969/j.issn.1004-583X.2019.03.015

Clinical Focus

Previous Articles Next Articles

LGI1 antibodyrelated limbic encephalitis: a case report and literature review

1. Department of Neurology, the First Affiliated Hospital of Nanjing Medical University,
Nanjing 210029, China; 2. Department of Neurology, Suzhou Municipal Hospital, Suzhou 215000, China

Online:2019-03-20 Published:2019-04-08
Contact: Corresponding author:Cheng Hong，Email：ch8706@hotmail.com

Abstract

Sun Mei1, Hou Xiaoxia2, Jin Shanquan1, Shen Feifei1, Cheng Hong1. LGI1 antibodyrelated limbic encephalitis: a case report and literature review[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2019.03.015.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2019.03.015

https://huicui.hebmu.edu.cn/EN/Y2019/V34/I3/273

[1]	Dong Siyu, Sun Mei, Tian Yufei, Cheng Hong, He Chuan. Delayed encephalitis after embolization of brain arteriovenous malformations: A case report and literature review [J]. Clinical Focus, 2023, 38(2): 170-174.
[2]	Hu Wencong, Liu Xiuzhen. Two cases of children's anti-MOG antibodies combined with anti-NMDAR antibody double positive autoimmune encephalitis and literature review [J]. Clinical Focus, 2022, 37(8): 733-737.
[3]	Li Qing, Zhong Wen, Liu Siqiang, Chen Yusheng, Li Hongru. Meta-analysis of PD-1/PD-L1 inhibitors in the treatment of patients with non-small cell lung cancer having brain metastases [J]. Clinical Focus, 2022, 37(5): 400-405.
[4]	Wang Xiaoqin, Zhou Youfeng, Lin Binrong. Exploring factors influencing adverse prognosis in children with acute encephalitis/ encephalopathy [J]. Clinical Focus, 2022, 37(11): 1017-1020.
[5]	Ye Qian, Ling Zhi, Yin Xudong. Sarcopenia on immune checkpoint inhibitors in solid tumor patients with sarcopenia: A meta-analysis [J]. Clinical Focus, 2022, 37(10): 889-898.
[6]	Tang Yingchao1, Li Xiaojia2, Zeng Quantao2, Ran Ningjing1, Xiao Wen1, Yang Dongdong1, Yang Xuhong1. One case of antiAMPAR encephalitis combined with myasthenia gravis and literature review [J]. Clinical Focus, 2020, 35(7): 639-642.
[7]	Mo Yijun1, Zhang Jianhua1, Yan Jun1, Lin Lina2. Treatment of advanced squamous nonsmall cell lung cancer with programmed cell death ligand 1 inhibitors: a report of two cases and literature review [J]. Clinical Focus, 2019, 34(3): 237-243.
[8]	Zhao Sena， Zhang Songb， Song Ninga， Jia Weihuaa， Yuan Shengfanga， Guo Xianlia. Interpretation of consensus guidelines for investigation and management of encephalitis in adults and children in Australia and New Zealand [J]. Clinical Focus, 2016, 31(12): 1370-1376.
[9]	LI Li-juan;GUO Xiao-jia;ZHANG Lian-sheng. Advances in treatment of diffuse large B-cell lymphoma [J]. Clinical Focus, 2014, 29(10): 1134-1139.
[10]	WEI Hui. Treatment of acute lymphoblastic leukemia [J]. Clinical Focus, 2014, 29(10): 1100-1103.

LGI1 antibodyrelated limbic encephalitis: a case report and literature review

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 10

Recommended Articles

Metrics

Comments